Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QRFPR | Q96P65 | 4/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
| ▸ | NPY4R | P50391 | 4/20 | 0.35 |
| ▸ | NPY1R | P25929 | 3/20 | 0.35 |
| ▸ | NPY2R | P49146 | 3/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.34 |
| ▸ | GNPAT | O15228 | 1/20 | 0.34 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.33 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29993120 | 1.00 | QRFPR (0.39) | QRFPRITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL29992949 | 0.99 | QRFPR (0.40) | QRFPRITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL29405094 | 0.95 | ITGB3 (0.38) | QRFPRITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL12646501 | 0.95 | ITGB3 (0.38) | QRFPRITGB3ITGA2BEPHX2NPY4R | |
| SCHEMBL30518017 | 0.92 | QRFPR (0.41) | QRFPRNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30997463 | 0.91 | QRFPR (0.41) | QRFPRNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29630426 | 0.90 | QRFPR (0.42) | QRFPRNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29590376 | 0.90 | QRFPR (0.42) | QRFPRNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31127533 | 0.89 | QRFPR (0.47) | QRFPRNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL14089438 | 0.89 | NPY4R (0.42) | ITGB3ITGA2BEPHX2NPY4RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542311-B2 | Fusion protein, preparation method therefor and application thereof in preparing ophthalmic disease treatment, anti-inflammation and anti-tumor medicament | JIANGSU RONGTAI BIOTECH CO., LTD. (CN) | 2023-01-03 | — | — | US | disclosed |
| US-11407811-B2 | Fusion protein, preparation method therefor and use thereof | JIANGSU RONGTAI BIOTECH CO., LTD. (CN) | 2022-08-09 | — | — | US | disclosed |
| US-20220202912-A1 | Polypeptides in Preparation of Drugs for Treatment or Prevention of Rheumatoid Arthritis | XU HANMEI (CN) | 2022-06-30 | — | — | US | disclosed |
| CN-108623693-B | Fusion protein, preparation method thereof and application thereof in preparing medicaments for treating ophthalmic diseases, anti-inflammatory and antitumor | 徐寒梅 | 2022-03-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220202912-A1 | Polypeptides in Preparation of Drugs for Treatment or Prevention of Rheumatoid Arthritis | ITGA2, ITGB3, ITGAV | QRFPR 191/4885ITGB3 2/4885ITGA2B 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.